← Eichor
Study identifier: NCT06552741 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

Condition: Substance Use Disorder · Alcohol Use Disorder  ·  Sponsor: National Institute on Drug Abuse (NIDA)

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersYes

About this study

Background: People who will participate in research studies need to undergo proper screening, evaluation, and assessment (SEA). SEA helps keep those who participate in studies safe. It also helps ensure accurate study results. The National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) wants to screen people with alcohol and/or substance use disorders (ASUD) as well as people without ASUD for ongoing studies at NIDA in Baltimore, MD Objective: To screen people with or without ASUD for ongoing studies at NIDA. The ultimate goals are to learn why some people (1) use drugs; (2) stop using drugs; (3) use drugs but do not get addicted; and (4) never use drugs snd to develop ASUD treatments. Eligibility: People aged 18 years and older. They may (1) currently use nicotine, alcohol, opioids, cocaine, or other drugs; (2) no longer use them; or (3) have never used them. Design: Participants will have 1 screening visit that could last up to 8 hours. The visit may be split over more than 1 day. The duration of the screening may vary for each individual based on which studies they are interested in and screened for. The tests they undergo may vary and may include the following: * Physical exam. * Blood, saliva, and urine tests. * Breath samples that test for alcohol and carbon monoxide. * Test of heart function. * Smell test that measures sense of smell. * Tests of memory, attention, and thinking. * Mental health evaluation. * Mock magnetic resonance imaging (MRI…

This description comes directly from the study's public registry record.

Talk to the study team

Shannon M Pfistner  ·  (800) 535-8254  ·  pfistners@nida.nih.gov

Lorenzo Leggio, M.D.  ·  (667) 312-5188  ·  lorenzo.leggio@nih.gov

Always discuss trial participation with your own doctor first.

Locations (1)

National Institute on Drug AbuseBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06552741